Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Yeungnam Med Sci > Volume 19(1); 2002 > Article
Review Nonmyeloablative stem cell transplantation.
Myung Soo Hyun
Journal of Yeungnam Medical Science 2002;19(1):11-27
DOI: https://doi.org/10.12701/yujm.2002.19.1.11
Published online: June 30, 2002
Division of Hemato-Oncology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Korea.
  • 1,436 Views
  • 0 Download
  • 0 Crossref
  • 0 Scopus

Allogenic hematopoietic stem cell transplantation is one of the effective therapy for several hematologic malignancies. Transplantation preparative regimen is designed to eradicate the patient's underlying disease and immunosuppress the patient adequately to prevent rejection of donor's hematopoietic stem cells. so, Conventional myeloablative preparative regimens with high-dose chemotherapy or radiotherapy are related to high rate of morbidity and mortality. however, It has become clear that the high-dose therapy dose not eradicate the malignancy in some patients, and that the therapeutic benefit of allogenic transplantation is largely related to graft-versus-leukemia/graft-versus-tumor (GVL/GVT) effect. An new approach is to utilize less toxic, nonmyeloablative preparative regimens to achieve engraftment and allow GVL/GVT effects to developed. This strategy reduces the risk of treatment-related mortality and allows transplantation for elderly and those with comorbidities that preclude high-dose chemoradiotherapy.

Related articles

JYMS : Journal of Yeungnam Medical Science